A patient with recalcitrant oral pemphigus vulgaris successfully treated with a biologic drug- Rituximab

A patient with recalcitrant oral pemphigus vulgaris successfully treated with a biologic drug- Rituximab

Pemphigus vulgaris (PV) is a chronic autoimmune blistering disease affecting mucous membranes and the skin. Rituximab (RTX), a monoclonal antibody against CD20, has been approved by FDA for the treatment of adults with moderate to severe PV. A 42-year-old Indian woman, previously diagnosed with oral...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Gunduz, Ozge, Modi, Zateen, Modi, Deepak
Hōputu: Online
Reo:Ingarihi
I whakaputaina: International Association for Dental Research (Nigeria Division) 2019
Urunga tuihono:https://ajoh.oauife.edu.ng/index.php/ajoh/article/view/41
Tags: Tāpirihia he Tūtohu
No Tags, Be the first to tag this record!

Ngā tūemi rite

Ngā tūemi rite